Colorectal Cancer
Copyright ©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4337-4343
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4337
Table 2 (PDF) Up- and down-regulated genes in NS398-treated LoVo cells for 48 h (mean±SD)
Accession numberGene descriptionRatio
Not foundHs.23723, “ESTs” (346390)3.41±1.76
Not foundHs.106513, “EST” (348242)3.05±1.88
BC040844Hs.198253, NS1-associated protein 1 (435598)2.51±0.53
AF257505Hs.23317, butyrophilin, subfamily 3, member A2 (219410)2.12±0.56
NT_033899Hs.28043, KIAA0712 gene product (219914)2.13±0.40
BC011714Hs.9605, heterogeneous nuclear ribonucleoprotein D-like (190165)2.34±0.51
M62782Hs.22907, human insulin-like growth factor binding protein 5 (IGFBP5) mRNA (31397)2.15±0.43
NM_003127Hs.87497, spectrin, alpha, non-erythrocytic 1 (alpha-fodrin, 3021698)2.14±0.13
BC008005Hs.116459, nucleotide binding protein 2 (E coli MinD like, 2498589)2.01±0.29
Not foundHs.43913, ESTs (2498857)2.20±0.28
Not foundHs.272073, ESTs (1296662)2.33±0.43
BM508995Hs.106513, ESTs, highly similar to proteasome (H sapiens, 1302647)2.47±0.76
NM_000624Hs.150580, alpha-1-antichymotrypsin (1322220)2.14±0.35
AF248734Hs.87497, apoptotic protease activating factor (963055)2.28±0.45
BC002965Lysosomal-associated membrane protein 2 (LAMP2), transcript variant LAMP2A (134418)2.34±0.69
NM_006536Chloride channel, calcium activated, family member 2 (CLCA2, 781187)2.39±0.42
M90657Tumor-associated antigen L6 (1964132)2.85±1.58
Not foundSpliceosome associated protein 145 (1964680)2.28±0.34
AW674474Putative insulin-like growth factor ii associated (229316)2.32±0.50
AF041835Laminin, gamma 3 (LAMC3, 2497685)2.16±0.48
AB019987Chromosome-associated polypeptide-c (2597847)2.06±0.09
AW277011Putative vacuolar protein sorting-associated protein c (2744695)2.20±0.64
BC032547Homeo box A1 (HOXA1, 3923611)2.27±1.18
NM_003391Wingless-type MMTV integration site family member 2 (WNT2, 149373)2.27±0.28
BC027948c-fos induced growth factor (VEGF D, FIGF, 160946)2.15±0.27
NM_001792Cadherin 2, N-cadherin (neuronal, CDH2, 3617894)2.03±0.10
NM_001964Early growth response 1 (EGR1, 182411)2.61±0.47
AF071400Plasminogen activator inhibitor, type II (arginine-serpin, PAI2, 323255)2.41±0.39
NM_002447Macrophage stimulating 1 receptor (c-met-related tyrosine kinase, MST1R, 586698)2.45±0.62
NM_003254Tissue inhibitor of metalloproteinase 1 (erythroid potentiating activity,
collagenase inhibitor, TIMP1, 771755)2.02±0.18
NM_003182Tachykinin, precursor 1 (substance K, substance P, neurokinin 1, neurokinin 2, neuromedin L,2.22±0.30
neurokinin alpha, neuropeptide K, neuropeptide gamma, TAC1), transcript variant beta (784179)
BC004986Hs.77202, ribosomal protein S25 (178052)0.49±0.06
BC035128Hs.23317, Max-interacting protein (130696)0.45±0.05
Not foundHs.23954, ESTs (132543)0.51±0.06
AJ001810Hs.106513, pre-mRNA cleavage factor Im (25 ku)0.48±0.01
BC05352166834, Hs.76847, spectrin, alpha, non-erythrocytic 1 (alpha-fodrin, 31230)0.47±0.15
M64716Hs.234726, ribosomal protein S25 (4932742)0.46±0.05
BC032589No, beta-2-microglobulin (1907327)0.48±0.11
Not foundHs.45209, EST (2118886)0.47±0.11
NT_024524Hs.15058, PIBF1 gene product (1596167)0.50±0.05
NM_001779CD58 antigen (lymphocyte function-associated antigen 3, CD58, 490368)0.50±0.15
NM_002228v-jun avian sarcoma virus 17 oncogene homolog (JUN, 823612)0.41±0.11
NM_020979Adaptor protein with pleckstrin homology and src homology 2 domains (APS, 3056093)0.49±0.17
NM_000059Breast cancer 2, early onset (BRCA2, 3850805)0.30±0.10
NM_001223Caspase 1, apoptosis-related cysteine protease (interleukin 1, beta, convertase, CASP1, 3858119)0.48±0.09